Systemic Inflammation-Related Bradycardia in COVID-19

Authors

Ashwin Srinivasan, HCA HealthcareFollow
Tusharkumar Pansuriya, HCA HealthcareFollow
Branden Wilson, HCA HealthcareFollow
Siva Sarva, HCA HealthcareFollow
Turuvekere Jayaram, HCA HealthcareFollow
Salman Alim, HCA HealthcareFollow
Ramesh Kesavan, HCA HealthcareFollow
Syed Raza, HCA HealthcareFollow

Division

Gulf Coast

Hospital

HCA Houston Healthcare Kingwood

Document Type

Case Report

Publication Date

9-17-2021

Keywords

sars-cov-2, coronavirus infections, COVID-19, sinus bradycardia

Disciplines

Cardiology | Cardiovascular Diseases | Internal Medicine | Virus Diseases

Abstract

Systemic inflammation-related sinus bradycardia in COVID-19 infection has not been well described yet. This six-patient case series excludes common causes of bradycardia. As bradycardia may be a sequela of COVID-19 infection, we recommend closely monitoring hemodynamics and stopping medications that can exacerbate bradycardia in these patients.

Publisher or Conference

Case Reports in Cardiology

Recommended Citation

Srinivasan A, Pansuriya T, Wilson B, et al. Systemic Inflammation-Related Bradycardia in COVID-19. Case Rep in Cardiology. 2021;2021:9986955. https://doi.org/10.1155/2021/9986955